{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T09:08:05Z","timestamp":1720775285291},"reference-count":46,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":581,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/ijcp.12337","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T02:58:41Z","timestamp":1390964321000},"page":"304-313","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis"],"prefix":"10.1155","volume":"68","author":[{"given":"P.","family":"Rys","sequence":"first","affiliation":[{"name":"HTA Consulting; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wojciechowski","sequence":"additional","affiliation":[{"name":"HTA Consulting; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Siejka","sequence":"additional","affiliation":[{"name":"HTA Consulting; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ma\u0142ecki","sequence":"additional","affiliation":[{"name":"Novo Nordisk Pharma; Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141.","family":"Hak","sequence":"additional","affiliation":[{"name":"Novo Nordisk Pharma; Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Malecki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases; Jagiellonian University Medical College; Krakow Poland"},{"name":"University Hospital; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,1,28]]},"reference":[{"issue":"Suppl. 1","key":"10.1111\/ijcp.12337-BIB0001|ijcp12337-cit-0001","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes-2011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0002|ijcp12337-cit-0002","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12337-BIB0003|ijcp12337-cit-0003","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12337-BIB0004|ijcp12337-cit-0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0005|ijcp12337-cit-0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/ijcp.12337-BIB0006|ijcp12337-cit-0006","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12337-BIB0007|ijcp12337-cit-0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.13.S1.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus","volume":"13","author":"Rodbard","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12337-BIB0008|ijcp12337-cit-0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMra040832","article-title":"Insulin analogues","volume":"352","author":"Hirsch","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12337-BIB0009|ijcp12337-cit-0009","doi-asserted-by":"crossref","first-page":"178372","DOI":"10.1155\/2010\/178372","article-title":"Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps","volume":"2010","author":"Valla","year":"2010","journal-title":"Exp Diabetes Res"},{"key":"10.1111\/ijcp.12337-BIB0010|ijcp12337-cit-0010","first-page":"919","article-title":"Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes","volume":"3","author":"Raja-Khan","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1111\/ijcp.12337-BIB0011|ijcp12337-cit-0011","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0012|ijcp12337-cit-0012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2004.10.001","article-title":"Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes","volume":"15","author":"Boehm","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1111\/ijcp.12337-BIB0013|ijcp12337-cit-0013","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1463-1326.2006.00654.x","article-title":"Premixed insulin treatment for type 2 diabetes: analogue or human?","volume":"9","author":"Garber","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12337-BIB0014|ijcp12337-cit-0014","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00125-009-1468-7","article-title":"Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses","volume":"52","author":"Lasserson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12337-BIB0015|ijcp12337-cit-0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/dc10-1710","article-title":"Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials","volume":"34","author":"Giugliano","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0016|ijcp12337-cit-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1111\/ijcp.12337-BIB0017|ijcp12337-cit-0017","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1111\/ijcp.12337-BIB0018|ijcp12337-cit-0018","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/dia.2006.0016","article-title":"Comparison of once-daily glargine plus sulfonylurea with twice-daily 70\/30 aspart premix in insulin-naive Japanese patients with diabetes","volume":"9","author":"Tamemoto","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"10.1111\/ijcp.12337-BIB0019|ijcp12337-cit-0019","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-2006-949655","article-title":"Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride","volume":"114","author":"Kann","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/ijcp.12337-BIB0020|ijcp12337-cit-0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diacare.28.2.260","article-title":"Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs","volume":"28","author":"Raskin","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0021|ijcp12337-cit-0021","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1185\/03007990903354674","article-title":"Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT","volume":"25","author":"Strojek","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12337-BIB0022|ijcp12337-cit-0022","first-page":"A622","article-title":"BIAsp 30 once daily is well tolerated and non-inferior to insulin glargine once daily both in combination with metformin and glimepiride in Chinese and Japanese subjects with type 2 diabetes","volume":"61","author":"Yang","year":"2012","journal-title":"Diabates"},{"key":"10.1111\/ijcp.12337-BIB0023|ijcp12337-cit-0023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4158\/EP10079.OR","article-title":"A comparison of twice-daily biphasic insulin aspart 70\/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study","volume":"17","author":"Ligthelm","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12337-BIB0024|ijcp12337-cit-0024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diabres.2005.12.009","article-title":"Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy","volume":"73","author":"Yokoyama","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/ijcp.12337-BIB0025|ijcp12337-cit-0025","unstructured":"Statens Serum Institut - Statistikker http:\/\/medstat.dk\/"},{"key":"10.1111\/ijcp.12337-BIB0026|ijcp12337-cit-0026","unstructured":"Norwegian Prescription Database http:\/\/www.norpd.no\/"},{"key":"10.1111\/ijcp.12337-BIB0027|ijcp12337-cit-0027","unstructured":"Statistikdatabaser - L\u00e4kemedelsstatistik - Val http:\/\/192.137.163.49\/sdb\/lak\/val.aspx"},{"key":"10.1111\/ijcp.12337-BIB0028|ijcp12337-cit-0028","unstructured":"GIPdatabank [Internet] http:\/\/www.gipdatabank.nl\/"},{"key":"10.1111\/ijcp.12337-BIB0029|ijcp12337-cit-0029","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1463-1326.2007.00826.x","article-title":"Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study","volume":"10","author":"Khutsoane","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12337-BIB0030|ijcp12337-cit-0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1742-1241.2009.02002.x","article-title":"Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30\/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study","volume":"63","author":"Valensi","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12337-BIB0031|ijcp12337-cit-0031","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1463-1326.2011.01394.x","article-title":"Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine vs. NPH insulin in type 2 diabetes","volume":"13","author":"Rhoads","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12337-BIB0032|ijcp12337-cit-0032","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12337-BIB0033|ijcp12337-cit-0033","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1185\/030079905X74989","article-title":"Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30\/70 versus insulin glargine in insulin na\u00efve type 2 diabetes patients: cost-effectiveness analysis in the UK setting","volume":"21","author":"Valentine","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12337-BIB0034|ijcp12337-cit-0034","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"U.K. prospective diabetes study 16. Overview of 6\u00a0years' therapy of type II diabetes: a progressive disease","volume":"44","author":"U.K. Prospective Diabetes Study Group","year":"1995","journal-title":"Diabetes"},{"key":"10.1111\/ijcp.12337-BIB0035|ijcp12337-cit-0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"DCCT Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12337-BIB0036|ijcp12337-cit-0036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pcd.2011.02.003","article-title":"Initiation of biphasic insulin aspart 30\/70 in subjects with type 2 diabetes mellitus in a largely primary care-based setting in Sweden","volume":"5","author":"Berntorp","year":"2011","journal-title":"Prim Care Diabetes"},{"key":"10.1111\/ijcp.12337-BIB0037|ijcp12337-cit-0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14740338.2013.761971","article-title":"Multicenter, open-label, non-randomized, non-interventional observational study of safety of treatment initiation with a biphasic insulin aspart","volume":"12","author":"Wolnik","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/ijcp.12337-BIB0038|ijcp12337-cit-0038","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4158\/EP10348.OR","article-title":"Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy","volume":"17","author":"Herman","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12337-BIB0039|ijcp12337-cit-0039","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12337-BIB0040|ijcp12337-cit-0040","unstructured":"International Diabetes Federation Clinical Guidelines Task Force. Global guideline for type 2 diabetes 2012 http:\/\/www.idf.org\/sites\/default\/files\/IDF%20T2DM%20Guideline.pdf"},{"key":"10.1111\/ijcp.12337-BIB0041|ijcp12337-cit-0041","unstructured":"Global IDF\/ISPAD guideline for diabetes in childhood and adolescence 2011 http:\/\/www.ispad.org\/sites\/default\/files\/resources\/files\/idf-ispad_diabetes_in_childhood_and_adolescence_guidelines_2011_0.pdf"},{"key":"10.1111\/ijcp.12337-BIB0042|ijcp12337-cit-0042","unstructured":"National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update) London Royal College of Physicians 2008 http:\/\/www.nice.org.uk\/nicemedia\/live\/11983\/40803\/40803.pdf"},{"key":"10.1111\/ijcp.12337-BIB0043|ijcp12337-cit-0043","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","article-title":"Three-year efficacy of complex insulin regimens in type 2 diabetes","volume":"361","author":"Holman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12337-BIB0044|ijcp12337-cit-0044","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1463-1326.2010.01239.x","article-title":"Predictors of responders to insulin therapy at 1\u00a0year among adults with type 2 diabetes","volume":"12","author":"Owen","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12337-BIB0045|ijcp12337-cit-0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s001250051172","article-title":"Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus","volume":"42","author":"M\u00e4kimattila","year":"1999","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12337-BIB0046|ijcp12337-cit-0046","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes","volume":"6","author":"Lee","year":"1998","journal-title":"Obes Res"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12337","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:07:55Z","timestamp":1643350075000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,28]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12337","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,28]]},"assertion":[{"value":"2014-01-28","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}